← Back to Search

Integrated PTSD & Nightmare Therapy for Post-Traumatic Stress Disorder (CPTERRT Trial)

N/A

Recruiting

Led By Joanne l Davis, PhD

Research Sponsored by University of Tulsa

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

meet full criteria for PTSD

18 Years of Age minimal

Must not have

17 years of age or younger

Timeline

Screening 3 weeks

Treatment Varies

Follow Up past month symptoms measured at baseline, and 3 and 6 month follow-up

Awards & highlights

No Placebo-Only Group

Summary

This trial is studying a possible new treatment for PTSD that integrates exposure, relaxation, and rescripting therapy with cognitive processing therapy.

Who is the study for?

This trial is for adults who have experienced trauma, suffer from PTSD with at least one nightmare per week over the past month. It's not suitable for individuals under 18, those with active suicidal thoughts, recent substance abuse disorders, acute psychosis, bipolar disorder or intellectual disability.

What is being tested?

The study tests if combining two therapies—Cognitive Processing Therapy (CPT) and Exposure, Relaxation and Rescripting Therapy (ERRT)—is more effective for treating PTSD and related nightmares than CPT alone. Participants will receive either both treatments in sequence or just CPT.

What are the potential side effects?

Potential side effects may include increased distress due to recalling traumatic events during therapy sessions. As these are psychological interventions rather than medications, traditional physical side effects are not expected.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have been diagnosed with PTSD.

Select...

I am at least 18 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I am 17 years old or younger.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ past month symptoms measured at baseline, and 3 and 6 month follow-up

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~past month symptoms measured at baseline, and 3 and 6 month follow-up

This trial's timeline: 3 weeks for screening, Varies for treatment, and past month symptoms measured at baseline, and 3 and 6 month follow-up for reporting.